Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jaime Zorrilla has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An Individualized Low-Pneumoperitoneum-Pressure Strategy May Prevent a Reduction in Liver Perfusion during Colorectal Laparoscopic Surgery

    by Luis Enrique Olmedilla Arnal, Oscar Diaz Cambronero, Guido Mazzinari, José María Pérez Peña, Jaime Zorrilla Ortúzar, Marcos Rodríguez Martín, Maria Vila Montañes, Marcus J. Schultz, Lucas Rovira, Maria Pilar Argente Navarro, et al.

    High intra-abdominal pressure (IAP) during laparoscopic surgery is associated with reduced splanchnic blood flow. It is uncertain whether a low IAP prevents this reduction. We assessed the effect of an individualized low-pneumoperitoneum-pressure strategy on liver perfusion. This was a single-center substudy of the multicenter ‘Individualized Pneumoperitoneum Pressure in Colorectal Laparoscopic Surgery versus Standard Therapy II study’ (IPPCollapse–II), a randomized clinical trial in which patients received an individualized low-pneumoperitoneum strategy (IPP) or a standard pneumoperitoneum strategy (SPP). Liver perfusion was indirectly assessed by the indocyanine green plasma disappearance rate (ICG–PDR) and the secondary endpoint was ICG retention rate after 15 min (R15) using pulse spectrophotometry. Multivariable beta regression was used to assess the association between group assignment and ICG–PDR and ICG–R15. All 29 patients from the participating center were included. Median IAP was 8 (25th–75th percentile: 8–10) versus 12 (12,12) mmHg, in IPP and SPP patients, respectively (p < 0.001). ICG–PDR was higher (OR 1.42, 95%-CI 1.10–1.82; p = 0.006) and PDR–R15 was lower in IPP patients compared with SPP patients (OR 0.46, 95%-CI 0.29–0.73; p = 0.001). During laparoscopic colorectal surgery, an individualized low pneumoperitoneum may prevent a reduction in liver perfusion.


  • How to perform an anastomosis following a low anterior resection by transanal total mesorectal excision surgery: from top to bottom techniques

    by Patricia Tejedor, Luis Miguel Jimenez, Vicente Simó, Jorge Arredondo, Jaime Zorrilla, Carlos Pastor

    Aim: The aim was to describe the range of possibilities and our group's clinical outcomes when performing different types of anastomosis during transanal total mesorectal excision (taTME).Method: A retrospective analysis was performed based on four taTME series from 2016 to 2021. Inclusion criteria were patients with rectal cancer in whom a sphincter‐saving low anterior resection by taTME was performed. Four different techniques were employed for the anastomosis construction: (A) abdominal view, (B) transanal view, (C) hand‐sewn coloanal anastomosis and (D) pull‐through. Intra‐operative and postoperative data were collected and compared.Results: A total of 161 patients were included. Tumour height was lower in groups C and D (4 [3–5] vs. 7 [6–8] group A vs. 6 [5–7] group B, P = 0.000), requiring a hand‐sewn anastomosis. A transanal extraction of the specimen was more commonly performed in groups C and D (over 60% vs. 30% in groups A and B, P = 0.000). The rate of temporary stoma was similar between groups A, B and C (ranging from 84% to 98%) but was significantly lower in group D (P = 0.000). The overall rate of complications was similar between groups; however, group D had longer length of stay (15 days vs. 5–6 in groups A, B and C, P = 0.026).Conclusion: Every type of anastomosis construction after a taTME procedure seems to be safe and feasible and should be chosen based on surgeon's experience, tumour height and the length of the rectal cuff after the rectal transection. Colorectal surgeons should be familiar with these techniques in order to choose the one that benefits each patient the most.


  • Oncological safety of transanal total mesorectal excision (TaTME) for rectal cancer: mid-term results of a prospective multicentre study

    by Vicente Simo, Patricia Tejedor, Luis Miguel Jimenez, Cristina Hernan, Jaime Zorilla, Jorge Arrredondo, Fernando Lapuente, Carlos Pastor

    Background There is no consensus regarding the gold standard technique for rectal cancer as Total Mesorectal Excision (TME) may be safely performed either by open or minimally invasive surgery. The laparoscopic approach, however, may carry technical difficulties. For this reason, a novel technique has emerged in the last decade combining a dual laparoscopic dissection (abdominal and transanal) to perform the TME technique (TaTME). When focusing on oncological outcomes, there is a lack of literature regarding mid-long term results. The aim of this study is to evaluate the mid-term oncological impact of TaTME for treating rectal cancer. Methods A prospective multicentre study was performed in four tertiary centres including consecutive patients who underwent TaTME for mid-low rectal cancer by the same group of experienced surgeons. The analysed data included pathological results on the quality of TME and mid-term oncological outcomes. Results In total, 173 patients were included throughout a study period of 6 years. Our series included 70% males and 68% of patients with neoadjuvant treatments. The median follow-up was 23 [15–37.5] months. Regarding pathological results, a complete TME was achieved in 72.8%, while circumferential and distal margins were affected in 1.4 and 1.1%, respectively. Five patients developed local recurrences (3%) and 8.1% presented distant disease during the follow-up. The 2-year disease-free survival and the overall survival rates were 88% and 95%, respectively. Conclusions There is currently a lack of evidence in the literature regarding TaTME and oncological outcomes with no data available from randomized clinical trials. In the meantime, the reported results from different multicentre series are controversial. This study showed positive mid-term outcomes at 2 years of follow-up and supported notable oncological outcomes with TaTME. However, it must be emphasized that previous experience in minimally invasive and transanal surgeries is essential for surgeons before intending to perform TaTME.


  • ¿Estamos sobredosificando el metamizol por vía parenteral?

    by Alejandra Melgarejo-Ortuño, Almudena Ribed-Sánchez, Álvaro Giménez-Manzorro, Jaime Zorrila-Ortúzar, María Sanjurjo-Saez

  • A multifaceted individualized pneumoperitoneum strategy for laparoscopic colorectal surgery: a multicenter observational feasibility study

    by Oscar Diaz-Cambronero, Blas Flor Lorente, Guido Mazzinari, Maria Vila Montañes, Nuria García Gregorio, Daniel Robles Hernandez, Luis Enrique Olmedilla Arnal, Maria Pilar Argente Navarro, Marcus J. Schultz, Carlos L. Errando, et al.

    While guidelines for laparoscopic abdominal surgery advise using the lowest possible intra-abdominal pressure, commonly a standard pressure is used. We evaluated the feasibility of a predefined multifaceted individualized pneumoperitoneum strategy aiming at the lowest possible intra-abdominal pressure during laparoscopic colorectal surgery.


  • Postchemoradiation laparoscopic resection and intraoperative electron-beam radiation boost in locally advanced rectal cancer: long-term outcomes

    by Felipe A. Calvo, Claudio V. Sole, Javier Serrano, Marcos Rodriguez, Francisco Marcos, Alberto Muñoz-Calero, Jaime Zorrilla, Jose A. Lopez-Baena, Benjamin Diaz-Zorita, Jose Luis García-Sabrido, et al.

    In selected patients with rectal cancer, laparoscopic surgery is as safe as open surgery, with similar resection margins and completeness of resection. In addition, recovery is faster after laparoscopic surgery. We analyzed long-term outcomes in a group of patients with locally advanced rectal cancer (LARC) treated with preoperative therapy followed by laparoscopic surgery and intraoperative electron-beam radiotherapy (IOERT).


  • Aneurisma esplénico asociado a una fístula arteriovenosa hiliar

    by Alicia Ruiz De La Hermosa, Jaime Zorrilla Ortúzar, Marcos Rodríguez-Martín, José Luis Escat Cortés, Alberto Muñoz-Calero Peregrín

  • Top Cited Papers

    Expanded Adipose-Derived Stem Cells for the Treatment of Complex Perianal Fistula

    by Damian Garcia-Olmo, Dolores Herreros, Isabel Pascual, José Antonio Pascual, Emilio Del-Valle, Jaime Zorrilla, Paloma De-La-Quintana, Mariano Garcia-Arranz, Maria Pascual

    The feasibility and safety of stem cell-based therapy with expanded adipose-derived stem cells (ASCs) has been investigated in a phase I clinical trial. The present study was designed as a phase II multicenter, randomized controlled trial to further investigate the effectiveness and safety of ASCs in the treatment of complex perianal fistulas. Patients with complex perianal fistulas (cryptoglandular origin, n = 35; associated with Crohn's disease, n = 14) were randomly assigned to intralesional treatment with fibrin glue or fibrin glue plus 20 million ASCs. Fistula healing and quality of life (SF-12 questionnaire) were evaluated at eight weeks and one year. If healing was not seen at eight weeks, a second dose of fibrin glue or fibrin glue plus 40 million ASCs was administered. Fistula healing was observed in 17 (71 percent) of 24 patients who received ASCs in addition to fibrin glue compared with 4 (16 percent) of 25 patients who received fibrin glue alone (relative risk for healing, 4.43; confidence interval, 1.74-11.27); P < 0.001). The proportion of patients with healing was similar in Crohn's and non-Crohn's subgroups. ASCs were also more effective than fibrin glue alone in patients with a suprasphincteric fistulous tract (P = 0.001). Quality of life scores were higher in patients who received ASCs than in those who received fibrin glue alone. At one year follow-up, the recurrence rate in patients treated with ASCs was 17.6 percent. Both treatments were well tolerated. Administration of expanded ASCs (20 to 60 million cells) in combination with fibrin glue is an effective and safe treatment for complex perianal fistula and appears to achieve higher rates of healing than fibrin glue alone.


  • Fracturas de pelvis graves, lesiones asociadas e inestabilidad hemodinámica: incidencia, manejo y pronóstico en nuestro medio

    by Juan María Sánchez-Tocino, Fernando Turégano-Fuentes, Dolores Pérez-Díaz, Mercedes Sanz-Sánchez, Jesús Lago-Oliver, Jaime Zorrilla-Ortúzar, Darío Martínez-Baena


  • Prolapso rectal. ¿Abordaje abdominal o perineal? Estado actual

    by Fernando Muñoz, Emilio del Valle, Marcos Rodríguez, Jaime Zorrilla